13F reference period
n/a
Security Snapshot
FIRST TR EXCHANGE TRADED FD - HEITMAN GLOBAL (PRME) Institutional Ownership
CUSIP: 33739Q606
13F Institutional Holders and Ownership History from Q4 2015 to Q3 2019
Institutions Reporting
Shares (Excl. Options)
n/a
Price
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / HEITMAN GLOBAL
- Symbol
- PRME on Nasdaq
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- PRME - FIRST TR EXCHANGE TRADED FD - HEITMAN GLOBAL is tracked under CUSIP 33739Q606.
- 13F reference-period holder data is not available.
- Schedule 13D/13G significant owner rows are not currently available.
Change
- Holder data for the Q2 2026 reference period is not available.
- Available periods remain in the history table; they do not substitute for the headline period.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
33739Q606
13F reference period
n/a
13F holders
13D/G owners
0
CIK / CUSIP context first
PRME full holder history
Prime Medicine, Inc. SEC filings
Prime Medicine, Inc. company facts
Prime Medicine, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 33739Q606:
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
16
Headline period
n/a
Rows shown
1-16 of 16
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2019 Q3 | 0 | $0 | -$1,096,000 | 0 | |
| 2019 Q2 | 53,032 | $1,096,000 | +$223,418 | $20.68 | 4 |
| 2019 Q1 | 42,217 | $882,000 | +$308,014 | $20.87 | 4 |
| 2018 Q4 | 27,533 | $494,000 | -$450,617 | $17.94 | 5 |
| 2018 Q3 | 52,447 | $1,085,000 | +$899,253 | $20.69 | 4 |
| 2018 Q2 | 8,979 | $180,000 | -$209,000 | $19.89 | 3 |
| 2018 Q1 | 19,550 | $386,000 | +$369,000 | $19.76 | 3 |
| 2017 Q4 | 853 | $17,000 | -$216,000 | $19.95 | 2 |
| 2017 Q3 | 11,697 | $233,000 | -$3,307 | $19.91 | 2 |
| 2017 Q2 | 13,915 | $278,000 | -$174,397 | $19.98 | 3 |
| 2017 Q1 | 22,640 | $435,000 | -$877,412 | $19.30 | 2 |
| 2016 Q4 | 67,833 | $1,312,000 | +$675,870 | $19.33 | 5 |
| 2016 Q3 | 31,596 | $661,000 | +$59,687 | $20.97 | 4 |
| 2016 Q2 | 28,858 | $596,000 | +$269,000 | $20.82 | 4 |
| 2016 Q1 | 15,774 | $327,000 | +$56,983 | $20.72 | 3 |
| 2015 Q4 | 13,020 | $262,000 | +$262,000 | $20.07 | 2 |